Skip to content

Atinary and Takeda collaborate to drive innovation in healthcare

Share this article

Atinary Technologies, a Vaud based startup, announced a strategic collaboration with Takeda, Japanese largest pharmaceutical company.



This partnership brings together the two company’s complementary expertise, paving the way for innovative AI solutions poised to transform pharmaceutical R&D and accelerate drug discovery.

Through this collaboration, Takeda will leverage Atinary’s leading AI Self-Driving Labs technology, that combined with its expertise in R&D and drug discovery aim to create a more robust and efficient drug development process, ultimately benefiting patients worldwide.

Atinary is committed to harnessing the power of AI, data science, robotics, and cloud computing to dramatically accelerate the discovery and development of breakthrough molecules. This collaboration with Takeda Pharmaceuticals is a significant step towards achieving this goal.



Source: GGBa